Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2014, 141737

Opioid-induced Constipation: Pathophysiology, Clinical Consequences, and Management

Affiliations
Review

Opioid-induced Constipation: Pathophysiology, Clinical Consequences, and Management

Lalit Kumar et al. Gastroenterol Res Pract.

Abstract

Although opioids offer potent analgesia for severe acute and chronic noncancer pain, adverse gastrointestinal effects potentially undermine their clinical utility. In particular, between 40% and 95% of patients develop opioid-induced constipation (OIC). Therefore, there is a consensus that patients should commence laxatives at the start of opioid therapy and continue throughout treatment. Nevertheless, laxatives are not routinely coprescribed with opioids. Even when concurrent laxatives are prescribed, approximately half the patients treated for OIC do not achieve the desired improvement. Moreover, laxatives do not target the underlying cause of OIC (opioid binding to the μ -receptors in the enteric system) and as such are not very effective at managing OIC. The failure of lifestyle modification and laxatives to treat adequately many cases of OIC led to the concurrent use of peripherally acting opioid antagonists (such as methylnaltrexone bromide and naloxone) to reduce the incidence of gastrointestinal adverse events without compromising analgesia. Judicious use of the various options to manage OIC should allow more patients to benefit from opioid analgesia. Therefore, this paper reviews the causes, consequences, and management of OIC to help clinicians optimise opioid analgesia.

Figures

Figure 1
Figure 1
Treatment pathway for opioid-induced constipation.

Similar articles

See all similar articles

Cited by 31 PubMed Central articles

See all "Cited by" articles

References

    1. Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. European Addiction Research. 2012;18:228–245. - PubMed
    1. Alexander G, Kruszewski SP, Webster DW. Rethinking opioid prescribing to protect patient safety and public health. Journal of the American Medical Association. 2012;308:1865–1866. - PubMed
    1. NICE. Opioids in Palliative Care: Safe and Effective Prescribing of Strong Opioids for Pain in Palliative Care of Adults Clinical Guideline 140. London, UK: NICE; 2012.
    1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional Bowel Disorders. Gastroenterology. 2006;130(5):1480–1491. - PubMed
    1. Ueberall MA, Müller-Lissner S, Buschmann-Kramm C, Bosse B. The bowel function index for evaluating constipation in pain patients: definition of a reference range for a non- constipated population of pain patients. Journal of International Medical Research. 2011;39(1):41–50. - PubMed
Feedback